6 Common Drugs Used for UTI (urinary tract infection) Prophylaxis in Children

Urinary Tract Infection (UTI) in Children — Introduction

Urinary tract infection (UTI) (outlink to CDC) is one of the most common serious bacterial infections in childhood and an important cause of fever, morbidity, and potential long-term renal damage. UTIs involve infection of the urinary system, including the bladder (cystitis) and kidneys (pyelonephritis). Early recognition and appropriate management are essential to prevent complications such as renal scarring, hypertension, and chronic kidney disease.

Epidemiology

UTIs occur in approximately 5–8% of girls and 1–2% of boys by 7 years of age. During infancy, UTIs are more common in boys, especially those who are uncircumcised. After the first year of life, girls are affected more frequently due to anatomical and behavioral factors.

Causative Agents

The most common causative organism is Escherichia coli, accounting for the majority of infections. Other pathogens include Klebsiella, Proteus, Enterococcus, and Pseudomonas aeruginosa, particularly in children with structural abnormalities or catheterization. Link to Genitourinary system MCQs

Risk factors and Presentation

Risk factors include vesicoureteral reflux, urinary tract obstruction, neurogenic bladder, constipation, poor perineal hygiene, and dysfunctional voiding. Clinical presentation varies with age: neonates and infants may present with nonspecific signs such as fever, poor feeding, vomiting, or irritability, whereas older children typically present with dysuria, frequency, urgency, abdominal pain, or flank pain.

Prevention

Because recurrent infections increase the risk of renal scarring, identifying children at risk and initiating preventive strategies — including behavioral measures and, when indicated, antibiotic prophylaxis — is an important component of pediatric care.

UTI Prophylaxis in Children

DrugDose (once daily unless stated)Age suitabilityWhen preferredImportant notes
Nitrofurantoin1–2 mg/kg at bedtime>1 monthFirst-line prophylaxisAvoid if G6PD deficiency; may cause nausea
Trimethoprim-Sulfamethoxazole (TMP-SMX)2 mg/kg (TMP component)>2 monthsCommon first choiceAvoid in neonates; risk of Stevens-Johnson syndrome
Trimethoprim alone2 mg/kg>2 monthsAlternative to TMP-SMXUseful if sulfa allergy
Cephalexin10–12 mg/kgAll agesInfants & vesicoureteral refluxGood safety profile
Amoxicillin10–15 mg/kg<2 monthsNeonatal prophylaxisResistance common after infancy
Cefixime2 mg/kg>6 monthsResistant organismsUsed less commonly

Indications for UTI Prophylaxis

  • Vesicoureteral reflux (Grade III–V)
  • Recurrent febrile UTIs (≥2 in 6 months or ≥3/year)
  • Obstructive uropathy awaiting surgery
  • Neurogenic bladder
  • After first febrile UTI in infants until evaluation complete

Duration

  • Continue until:
    • VUR resolves or is surgically corrected
    • Child becomes toilet trained and infection-free
    • Specialist review recommends stopping

Key Clinical Points

✔ Give at bedtime for maximal bladder concentration
✔ Encourage hydration & regular voiding
✔ Treat constipation (important risk factor)
✔ Monitor for breakthrough infections and resistance

Treatment of UTI in Children

Empirical Antibiotic Therapy (Based on Clinical Type)

Clinical TypeOral Antibiotics (Outpatient)IV Antibiotics (Inpatient / Severe)Duration
Simple cystitis (Afebrile UTI)Nitrofurantoin 5–7 mg/kg/day ÷ 2 doses
Cephalexin 50–100 mg/kg/day ÷ 3–4 doses
TMP-SMX 8–10 mg/kg/day (TMP component) ÷ 2 doses
Usually not required5–7 days
Febrile UTI / Acute pyelonephritisCefixime 8 mg/kg/day OD
Amoxicillin-clavulanate 40–50 mg/kg/day ÷ 2–3 doses
Ceftriaxone 50–75 mg/kg OD
Cefotaxime 150 mg/kg/day ÷ 3 doses
Gentamicin 5–7 mg/kg OD
7–14 days
Neonatal UTI (<2 months)Not preferredAmpicillin + Gentamicin
OR Cefotaxime
10–14 days
Complicated UTI / Toxic childNot preferredCeftriaxone ± Amikacin
Consider Piperacillin-Tazobactam if resistant
10–14 days

Organism-Specific Considerations

OrganismPreferred Drugs
Escherichia coliCephalosporins, Nitrofurantoin, TMP-SMX (if sensitive)
ProteusAvoid Nitrofurantoin; use cephalosporins
Pseudomonas aeruginosaCeftazidime, Piperacillin-Tazobactam
EnterococcusAmpicillin, Amoxicillin

Supportive Management

MeasureDetails
HydrationEncourage oral fluids
AntipyreticsParacetamol / Ibuprofen
Treat constipationImportant to prevent recurrence
Follow-up cultureIf no improvement in 48 hours
ImagingRBUS after first febrile UTI (especially <2 years)

Important Clinical Points

✔ Send urine routine + culture before starting antibiotics
✔ Switch from IV to oral once clinically improved (24–48 hrs)
✔ Modify antibiotics according to culture sensitivity
✔ Admit if: toxic appearance, persistent vomiting, dehydration, neonate, poor follow-up

CROUP (Acute Laryngotracheobronchitis)


Definition

Croup is an acute viral inflammatory disease of the upper airway involving the larynx, trachea, and bronchi, leading to subglottic edema and airway obstruction.


Epidemiology

  • Age: 6 months – 3 years (can occur up to 6 years)
  • Male > Female
  • Peak: Autumn & early winter
  • Usually preceded by URTI

Etiology

Viral (most common)

  • Parainfluenza virus type 1 (most common)
  • Parainfluenza 2 & 3
  • RSV
  • Influenza A & B
  • Adenovirus
  • Human metapneumovirus

Rare bacterial causes

  • Mycoplasma
  • Secondary bacterial infection (uncommon)

Pathophysiology

  • Viral infection → inflammation & edema of subglottic region
  • Subglottis is the narrowest part of pediatric airway
  • Small edema → marked increase in airway resistance
  • Leads to inspiratory stridor & respiratory distress

Clinical Features

Prodrome

  • Low-grade fever
  • Coryza
  • Cough

Characteristic features

  • Barking (seal-like) cough
  • Hoarseness
  • Inspiratory stridor
  • Worse at night
  • Aggravated by crying & agitation

Severe disease

  • Stridor at rest
  • Chest retractions
  • Tachypnea
  • Hypoxia
  • Fatigue / altered sensorium (late sign)

Severity Assessment (Westley Croup Score – concept)

FeatureMildModerateSevere
StridorNone / with agitationAt restLoud, biphasic
RetractionsNoneMild–moderateSevere
Air entryNormalDecreasedMarkedly reduced
CyanosisNoneNonePresent
Mental statusNormalNormalAltered

Investigations

  • Diagnosis is clinical
  • No routine labs required
  • Neck X-ray (AP) (only if diagnosis unclear):
    • Steeple sign (subglottic narrowing)

Differential Diagnosis

ConditionKey Differentiating Feature
EpiglottitisHigh fever, drooling, muffled voice
Bacterial tracheitisToxic child, high fever
Foreign bodySudden onset, no prodrome
Retropharyngeal abscessNeck stiffness, drooling
AngioedemaFacial/lip swelling

Management

General Measures

  • Keep child calm
  • Minimal handling
  • Oxygen if hypoxic
  • Humidified air (comfort measure only)

Pharmacological Treatment

1️⃣ Corticosteroids (All cases)

Dexamethasone (Dexona)

  • Dose: 0.6 mg/kg
  • Max: 10 mg
  • Route: Oral / IM / IV
  • Single dose usually sufficient

2️⃣ Adrenaline Nebulization (Moderate–Severe)

L-Adrenaline (1:1000)

  • Dose: 0.5 mL/kg (max 5 mL)
  • Dilute with NS to 5 mL
  • Rapid onset (10–15 min)
  • Duration: ~2 hours

⚠️ Observe 2–4 hours after neb (rebound stridor)


Indications for Admission

  • Stridor at rest
  • Need for repeated adrenaline
  • Hypoxia
  • Poor oral intake
  • Age < 6 months
  • Social concerns

Indications for ICU / Intubation

  • Exhaustion
  • Altered consciousness
  • Severe hypoxia
  • Poor air entry
  • Failure to respond to treatment

Complications

  • Respiratory failure
  • Secondary bacterial infection
  • Pneumonia
  • Rarely death

Prognosis

  • Excellent
  • Self-limiting (3–7 days)
  • Recurrence possible

Key Takeaway

  • Single dose dexamethasone for all croup
  • Adrenaline = temporary relief
  • Steeple sign = croup
  • Drooling → think epiglottitis
  • Avoid agitation at all costs

Exit mobile version